Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | PPARG | P37231 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | STS | P08842 | 1/20 | 0.58 |
| ▸ | CTSV | O60911 | 2/20 | 0.50 |
| ▸ | CTSL | P07711 | 2/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.50 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28050777 | 1.00 | ALOX15 (0.66) | ALOX15PPARGMAPTSTSCTSV | |
| SCHEMBL16893235 | 1.00 | ALOX15 (0.66) | ALOX15PPARGMAPTSTSCTSV | |
| SCHEMBL21166318 | 1.00 | ALOX15 (0.66) | ALOX15PPARGMAPTSTSCTSV | |
| SCHEMBL3657376 | 1.00 | ALOX15 (0.66) | ALOX15PPARGMAPTSTSCTSV | |
| SCHEMBL3654554 | 1.00 | ALOX15 (0.66) | ALOX15PPARGMAPTSTSCTSV | |
| SCHEMBL3662892 | 0.98 | ALOX15 (0.68) | ALOX15PPARGMAPTSTSCTSV | |
| SCHEMBL3660694 | 0.94 | PPARG (0.65) | ALOX15PPARGMAPTSTSCYP11B1 | |
| SCHEMBL28428768 | 0.90 | ALOX15 (0.58) | ALOX15PPARGMAPTSTSCYP11B1 | |
| SCHEMBL30694898 | 0.87 | PPARG (0.69) | ALOX15PPARGSTSCYP11B1CYP11B2 | |
| SCHEMBL3715533 | 0.87 | PPARG (0.69) | ALOX15PPARGSTSCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11642288-B2 | Skin external composition | KAO CORPORATION (JP) | 2023-05-09 | — | — | US | disclosed |
| CN-111491604-B | Method for producing composition containing hardly water-soluble aromatic compound | 花王株式会社 | 2023-03-21 | — | — | CN | disclosed |
| EP-4104862-A1 | SKIN COMPOSITION FOR EXTERNAL USE | Kao Corporation (JP) | 2022-12-21 | — | — | EP | disclosed |
| EP-3733155-B1 | METHOD FOR MANUFACTURING COMPOSITION THAT INCLUDES POORLY WATER-SOLUBLE AROMATIC COMPOUND | KAO CORP (JP) | 2022-11-23 | — | — | EP | disclosed |
| US-20220287923-A1 | SKIN EXTERNAL COMPOSITION | KAO CORPORATION (JP) | 2022-09-15 | — | — | US | disclosed |
| US-11419797-B2 | Method for producing composition containing hardly water-soluble aromatic compound | KAO CORPORATION (JP) | 2022-08-23 | — | — | US | disclosed |
| EP-4032524-A1 | METHOD FOR PRODUCING COMPOSITION CONTAINING HARDLY WATER-SOLUBLE AROMATIC COMPOUND | Kao Corporation (JP) | 2022-07-27 | — | — | EP | disclosed |
| CN-113950336-A | Composition for external application to skin | 花王株式会社 | 2022-01-18 | — | — | CN | disclosed |
| US-20210059909-A1 | METHOD FOR PRODUCING COMPOSITION CONTAINING HARDLY WATER-SOLUBLE AROMATIC COMPOUND | KAO CORPORATION (JP) | 2021-03-04 | — | — | US | disclosed |
| EP-3733155-A1 | METHOD FOR MANUFACTURING COMPOSITION THAT INCLUDES POORLY WATER-SOLUBLE AROMATIC COMPOUND | Kao Corporation (JP) | 2020-11-04 | — | — | EP | disclosed |
| US-9364424-B2 | Topical cosmetic skin lightening compositions and methods of use thereof | STIEFEL LABORATORIES, INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-20160074315-A1 | TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF | STIEFEL LABORATORIES, INC. | 2016-03-17 | — | — | US | disclosed |
| EP-2219600-A1 | TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF | STIEFEL LABORATORIES, INC. (US) | 2010-08-25 | — | — | EP | disclosed |
| WO-2009067095-A1 | TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF | STIEFEL LABORATORIES, INC. (US) | 2009-05-28 | — | — | WO | disclosed |
| EP-1602354-B1 | Use of polyglutamic acid or its salts | MEIJI SEIKA KAISHA (JP) | 2008-11-05 | — | — | EP | disclosed |
| EP-1604647-B1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | CHISSO CORP (JP) | 2008-05-07 | — | — | EP | disclosed |
| US-20060165636-A1 | Hair treatment composition and hair cosmetic for damaged hair | MEIJI SEIKA KAISHA, LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20060018867-A1 | Cosmetic composition and production thereof | ICHIMARU PHARCOS CO., LTD | 2006-01-26 | — | — | US | disclosed |
| EP-1604647-A1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | Ichimaru Pharcos Co., Ltd. (JP) | 2005-12-14 | — | — | EP | disclosed |
| EP-1602354-A1 | HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR | Meiji Seika Kaisha, Ltd. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060165636-A1 | Hair treatment composition and hair cosmetic for damaged hair | CUTA, COL14A1, PRKDC | ALOX15 3447/4885PPARG 1178/4885MAPT 648/4885 |
| US-20060018867-A1 | Cosmetic composition and production thereof | CUTA, PARG, TYR | ALOX15 670/4885PPARG 1824/4885MAPT 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.